Back to search
FDAFDA · Food and drugs·Recall number D-0120-2020

minolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample Not for Sale 5 Tablets, Rx Only, Mfg by: Dr. Reddy's Laboratories Limited, FTO-SEZ, Process Unit-01 Devunipalavalasa Village Srikakulam (District) Andhra Pradesh, INDIA. Manufactured for: EPI Health, LLC 134 Columbus St. Charleston, SC 29403 USA. NDC 71403-102-05.

Published October 2, 2019 · Recall initiated: August 26, 2019

Summary

FDA records drug Class III recall D-0120-2020, published October 2, 2019 and initiated August 26, 2019. Recalling firm: EPI Health, LLC; Status: Terminated; Reported quantity: 1,626 5-count bottles; Lot: Lot# T900093, Exp 11/2020. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications:

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
EPI Health, LLC
Distributor
Firm recalling only from EPI Field Representatives.
Lot
Lot# T900093, Exp 11/2020
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was minolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample Not for Sale 5 Tablets, Rx Only, Mfg by: Dr. Reddy's Laboratories Limited, FTO-SEZ, Process Unit-01 Devunipalavalasa Village Srikakulam (District) Andhra Pradesh, INDIA. Manufactured for: EPI Health, LLC 134 Columbus St. Charleston, SC 29403 USA. NDC 71403-102-05. recalled?

Yes. FDA published recall D-0120-2020 on October 2, 2019. Reported hazard: Failed Dissolution Specifications:

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail